Endophth Kit Recalled Due to Lack of Sterility Assurance
Pine Pharmaceuticals recalled an Endophth Kit (Vancomycin/Ceftazidime injectable) distributed nationwide due to lack of assurance of sterility. The recall affects 201 kits from lot 69986 (expires 11/15/2023).
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or hospitalizations, making it at most a score of 3 per the rubric. The hazard involves a high-risk injectable pharmaceutical where failure of sterility assurance poses a theoretical risk of microbial contamination, fitting the criterion 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Pine Pharmaceuticals has issued a recall of Endophth Kit (containing Vancomycin 1mg/0.1 mL and Ceftazidime 2.25mg/0.1 mL), an injectable pharmaceutical product used for treating infections. The recall affects 201 kits that were distributed nationwide.
The manufacturer recalled the product due to lack of assurance of sterility. As an injectable product, sterile manufacturing is critical to patient safety.
The affected lot number is 69986 with an expiration date of 11/15/2023. If you have received or administered this product, contact your healthcare provider or Pine Pharmaceuticals for guidance regarding potential replacement or alternative therapies.
The recalled product
- Product
- Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
- Manufacturer
- Pine Pharmaceuticals, LLC
- Category
- Drug — Injectable
- Affected units
- 201
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 69986
- Exp. Date 11/15/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Pine Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pine Pharmaceuticals, LLC
See all →- HighVancomycin Intraocular Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-10-25
- HighFDA Recalls Compounded Moxifloxacin Syringes for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighTPC Drops Ophthalmic Solution Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighFoscarnet Sodium Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighLidocaine eye drops recalled due to lack of sterility assurance
FDA (Drugs) · 2023-10-25
Same hazard · sterility risk
See all →- HighBaxter Recalls Vancomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereFDA Recalls Rohto Dry-Aid Eye Drops Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighMedline Medical Procedure Kits Recalled for High Endotoxin Levels
FDA (Devices) · 2026-05-06
- HighCook Medical tracheostomy introducer sets labeled with overstated expiration dates
FDA (Devices) · 2026-04-15